Households in Cambodia caught and consumed a far more diverse array of fish than they sold at market, highlighting how biodiversity loss might affect people’s nutrition, especially for those with lower incomes.
Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses.
An American Heart Association Presidential Advisory, co-authored by Mario Herrero, professor in global development, calls for building on existing research and implementing cross-sector approaches to Food Is Medicine.
Home health aides are vulnerable to stress, isolation and depressive symptoms, which impact their own health as well as their patients’ desire to age in place, according new research.
Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute have developed new AI tools tailored to digital pathology, a growing field that uses high-resolution digital images created from tissue samples to help diagnose disease.
The exhibition "Seeds of Survival and Celebration: Plants and the Black Experience" returned for a second season with an expanded plant collection, which honors the lasting influence of the formerly enslaved and their descendants on American culture.
One in five of the bacterial strains that cause typhoid fever have genetic variations in their external layer, called Vi capsule, that provide higher virulence, higher infectivity and high antibiotic resistance, Cornell researchers have discovered.
Women are at higher risk of death when undergoing heart bypass surgery than men, and researchers have determined that this disparity is mediated, to a large extent, by the loss of red blood cells during surgery.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
A multinational team led by Weill Cornell Medicine investigators developed a test for an HIV strain that disproportionately affects women and will benefit patients around the world.
